HIA
BIIB icon

HFM Investment Advisors’s Biogen BIIB Stock Holding History

HFM Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Buy
10
+5
+100% +$956 ﹤0.01% 428
2026
Q1 		$917 Hold
5
– – ﹤0.01% 441
2025
Q4 		$880 Buy
5
+4
+400% +$653 ﹤0.01% 499
2025
Q3 		$140 Sell
1
-1
-50% -$135 ﹤0.01% 1088
2025
Q2 		$251 Buy
2
+1
+100% +$125 ﹤0.01% 914
2025
Q1 		$137 Buy
+1
New +$143 ﹤0.01% 767

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HFM Investment Advisors's BIIB Position: Q2 2026 in Review

HFM Investment Advisors increased its Biogen (BIIB) stake by 100% in Q2 2026, buying an estimated $956 and bringing the position to 10 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

HFM Investment Advisors first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • HFM Investment Advisors held 10 shares of Biogen worth $2.16K as of Q2 2026.
  • HFM Investment Advisors bought 5 Biogen shares in Q2 2026, an estimated $956.
  • Biogen made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #428 holding.
  • HFM Investment Advisors first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.